When a board member uses this position for personal gain, the hospital’s purpose is lost, and those who rely on its care ...
Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...
In an interview with the Globe, Kate Walsh, the state secretary of health and human services, discussed how President Trump’s ...
The following is a summary of “Effect of early and later prone positioning on outcomes in invasively ventilated COVID-19 ...
Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer. Read why OLMA stock is a Hold.
Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at the 2025 ASCO GU meeting.
Last week, we released an Action Alert that provides a number of new advocacy resources on key issues — health care extenders, Medicaid, enhanced premium tax credits, so-called site-neutral payment ...
While there might not have been sufficient financial pressure for the sprawling 12-hospital system to overcome the hurdles of ...
Background Hospital readmissions are an important quality of care indicator and are tied to hospitals’ financial reimbursements. Safety-net hospitals, which serve a high proportion of patients of low ...
Researchers from Skoltech, prosthetics manufacturer Motorica, and Far Eastern Federal University have for the first time ...
A poorly positioned menstrual cup to capture monthly blood flow may lead to more serious complications than leakage alone, ...
When Mark Davidson walked into his doctor's office for a routine checkup, he had no idea he was about to become part of a medical revelation. His blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results